Clinical Briefs in Primary Care – May 1, 2005
May 1, 2005
View Issues
-
Clinical Briefs in Primary Care
Although we have recently enjoyed the FDA approval of two agents for treatment of diabetic peripheral neuropathic pain (duloxetine [Cymbalta], pregabalin [Lyrica]), as yet we have no treatment for diabetic peripheral neuropathy (DPN) itself.